Literature DB >> 28597215

Pharmacodynamics of Insulin Preparations Administered in Different Subcutaneous Injection Sites: Are There Differences Between Healthy Subjects Versus Diabetic Patients?

Nuggehally R Srinivas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28597215     DOI： 10.1007/s40261-017-0538-8

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN： 1173-2563            Impact factor:   2.859


× No keyword cloud information.
  10 in total

1.  Subcutaneous adipose tissue blood flow varies between superior and inferior levels of the anterior abdominal wall.

Authors:  J-L Ardilouze; F Karpe; J M Currie; K N Frayn; B A Fielding
Journal:  Int J Obes Relat Metab Disord       Date:  2004-02

2.  Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry.

Authors:  J P Vora; A Burch; J R Peters; D R Owens
Journal:  Diabetes Care       Date:  1992-11       Impact factor: 19.112

3.  Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients.

Authors:  V A Koivisto; P Felig
Journal:  Ann Intern Med       Date:  1980-01       Impact factor: 25.391

4.  Insulin absorption from the abdomen and the thigh in healthy subjects during rest and exercise: blood glucose, plasma insulin, growth hormone, adrenaline and noradrenaline levels.

Authors:  H Süsstrunk; B Morell; W H Ziegler; E R Froesch
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

5.  Impact of injection sites for soluble insulin on glycaemic control in type 1 (insulin-dependent) diabetic patients treated with a multiple insulin injection regimen.

Authors:  J E Henriksen; M S Djurhuus; A Vaag; P Thye-Rønn; D Knudsen; O Hother-Nielsen; H Beck-Nielsen
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

6.  Impaired postprandial adipose tissue blood flow response is related to aspects of insulin sensitivity.

Authors:  Fredrik Karpe; Barbara A Fielding; Vera Ilic; Ian A Macdonald; Lucinda K M Summers; Keith N Frayn
Journal:  Diabetes       Date:  2002-08       Impact factor: 9.461

7.  Insulin antibodies do not influence the absorption rate of subcutaneously injected insulin.

Authors:  P H de Meijer; J A Lutterman; A van't Laar
Journal:  Diabet Med       Date:  1988-11       Impact factor: 4.359

8.  Glucose-lowering effect of insulin degludec is independent of subcutaneous injection region.

Authors:  Leszek Nosek; Hans-Veit Coester; Carsten Roepstorff; Henrik F Thomsen; Niels R Kristensen; Hanne Haahr; Tim Heise
Journal:  Clin Drug Investig       Date:  2014-09       Impact factor: 2.859

9.  Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus.

Authors:  Tim Heise; Kirstine Stender-Petersen; Ulrike Hövelmann; Jacob Bonde Jacobsen; Leszek Nosek; Eric Zijlstra; Hanne Haahr
Journal:  Clin Pharmacokinet       Date:  2017-06       Impact factor: 6.447

10.  Pharmacokinetic Properties of Fast-Acting Insulin Aspart Administered in Different Subcutaneous Injection Regions.

Authors:  Ulrike Hövelmann; Tim Heise; Leszek Nosek; Bettina Sassenfeld; Karen Margrete Due Thomsen; Hanne Haahr
Journal:  Clin Drug Investig       Date:  2017-05       Impact factor: 2.859
  10 in total
  1 in total

1.  Pharmacokinetic Properties of Fast-acting Insulin Aspart Administered in Different Subcutaneous Injection Regions: Response to the commentary by Nuggehally R. Srinivas.

Authors:  Tim Heise; Ulrike Hövelmann; Leszek Nosek; Bettina Sassenfeld; Karen Margrete Due Thomsen; Hanne Haahr
Journal:  Clin Drug Investig       Date:  2017-09       Impact factor: 2.859
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.